VEN (Venetoclax) Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Venetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
Adult T-cell Leukemia/Lymphoma
The First Affiliated Hospital of Soochow University27 enrolled1 locationNCT07159620
Recruiting
Phase 2
Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes
Myelodysplastic NeoplasmsTransplantation
Yehui Tan46 enrolled1 locationNCT07047183